GlySens Incorporated logo — company profile

GlySens Incorporated

Founded 1998 United States San Diego, United States 5 employees Series D Total: $34.00M Health Care, Manufacturing +1

General Information

Company Name GlySens Incorporated
Founded Year 1998
Location United States San Diego, United States +1
Employees 5
Industries Health Care, Manufacturing, Medical Devices
Funding Stage Series D
Social

Get notified when GlySens Incorporated moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About GlySens Incorporated

GlySens is a health care and manufacturing startup based in the United States. Founded in 1998, the company is committed to revolutionizing diabetes care with their long-term, implantable continuous glucose monitoring technology. Their flagship product, the Eclipse® ICGM® System, is the world's first truly long-term, wireless, implantable, continuous glucose monitor.

With a $20.00M Series D investment led by Windham Venture Partners in January 04, 2016, GlySens has demonstrated strong investor support. Their vision is to empower individuals with diabetes through worry-free, at-a-glance technologies that provide crucial information for optimizing care, while allowing for a more flexible lifestyle.

GlySens' continuous dedication to pushing the boundaries of diabetes care makes them a compelling venture for potential investors seeking opportunities in the health care and medical device sector.

Taxonomy: Continuous Glucose Monitoring, Implantable Medical Device, Diabetes Technology, Glucose Sensor

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Series D •••••• 1
Investor
04 Jan 2016
Series C •••••• - 05 Jan 2015
Grant •••••• 1 •••• •••• 24 Nov 2014
Seed Round •••••• 1
Investor
14 Sep 2012

GlySens Incorporated Alternatives & Competitors

GlySens Incorporated vs

Freedom for people who use insulin.

Corporate Round
17 employees
Biotechnology, Health Care
GlySens Incorporated vs

Advancing the future of diabetes management through innovative technology.

IPO
280 employees
Biotechnology, Hardware
GlySens Incorporated vs

Innovative wearable diagnostic devices empowering individuals to manage and prevent diabetes through...

Post Ipo Debt
Health Care

FAQ About GlySens Incorporated

At GlySens®, we are dedicated to advancing the care of individuals with diabetes through the development of a long term, implantable continuous glucose monitoring technology. Since the company’s inception in 1998, we have focused on designing and developing the world’s first truly long term, wire...
GlySens Incorporated was founded in 1998.
GlySens Incorporated is headquartered in San Diego, United States.
GlySens Incorporated operates in the following industries: Health Care, Manufacturing, Medical Devices.
GlySens Incorporated has approximately 5 employees.
GlySens Incorporated has completed 4 funding rounds, raising a total of $34.00M. The latest funding stage is Series D.
Top alternatives and competitors to GlySens Incorporated include Portal Diabetes, Inc., Senseonics, Incorporated, Nemaura Medical, Undermyfork, sugar.fit. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
GlySens Incorporated and Portal Diabetes, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors GlySens Incorporated and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy